Xenetic Biosciences XBIO
NASDAQ XBIO
$2.24 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Gross Profit (2011 - 2017)

Updated

Xenetic Biosciences (XBIO) posted Gross Profit of -$12,028 for Q3 2017.

Analysis

Xenetic Biosciences (XBIO) Gross Profit (2011 - 2017) Analysis & Trends

For FY2013, Xenetic Biosciences' Gross Profit came in at $1 million, up 302.0% from FY2012.

  • In prior years, Xenetic Biosciences' Gross Profit was $248,765 in FY2012.
  • The Q3 2017 figure stands as the highest quarterly Gross Profit since Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Xenetic Biosciences 5.25 Mn -20.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -12,028.00
May 31, 2013 29,485.00
Feb 28, 2013 29,058.00
Nov 30, 2012 21,028.00
May 31, 2012 36,430.00
Feb 29, 2012 27,346.00
Nov 30, 2011 12,333.00
API Access

Xenetic Biosciences Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=XBIO&period=max&api_key=YOUR_API_KEY